COLUMN GROUP L P

Overview

See how the biggest companies compare on our leaderboards

Corporate structure

COLUMN GROUP L P sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Filings

5 filings to the SEC since October 2021: 5 other. The latest 5:

1. Apr 5, 2024SC TO-T/A EDGAR
2. Mar 22, 2024CORRESP EDGAR
3. Mar 22, 2024SC TO-T/A EDGAR
4. Mar 8, 2024SC TO-T EDGAR
5. Feb 26, 2024SC TO-C SCHEDULE TO-C EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

COLUMN GROUP L P has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

• NGM Biopharmaceuticals (United States)SC 13D/A Feb 3, 2022 to Apr 5, 2024²
• Nurix (United States)SC 13G/A Feb 11, 2022³